Monday, June 06, 2005
New Performance Measure and Management Tool Available Online SAMHSA press release - "The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced the online availability of SAMHSAs National Outcome Measures (NOMS) a data resource to help federal and state substance abuse and mental health managers facilitate evidence-based decision making and ultimately improve services in the communities they serve. 'This new web-based tool is the very beginning of a data reporting system that ultimately will provide a comprehensive state-by-state picture of mental health and substance abuse service system results,' said SAMHSA Administrator Charles Curie. 'This is a powerful new tool that we can use to improve the management and performance of our programs and make the most of the limited dollars available to help people attain and sustain recovery.' Using maps and charts, the database will describe states substance abuse and mental health prevalence, treatment and funding data. It will also provide substance abuse prevention data. As new data are collected, the website will also present cross-year data to help users examine program changes over time." See also the
NOMs web site.
Atypical Antipsychotics May Offer Benefits for AD Medscape Medical News story - "In a federally funded trial of atypical antipsychotic drugs to treat psychosis, agitation, and aggressiveness in patients with Alzheimer's disease (AD), researchers have found three leading drugs were associated with greater effectiveness, reduced burden for the caregiver, and improved neuropsychiatric symptoms compared with placebo, according to findings presented here at the 2005 American Psychiatric Association (APA) Annual Meeting. However, at preliminary analysis of the first of three phases of the trial, researchers were not able to find dramatic differences between the drugs olanzapine (Zyprexa), risperidone (Risperdal), and quetiapine (Seroquel). Still, each drug had a somewhat different adverse effect..."
New Medicaid Program Will Help Improve Quality of Care for Patients With Mental Illness (Michigan) PR Newswire story at
Yahoo - "The Michigan Department of Community Health (MDCH) has launched an innovative educational program that strives to improve the quality of care for Medicaid patients with mental illness. The Michigan Pharmacy Quality Improvement Project (PQIP), which began in May, is a two-year educational program that will analyze the prescribing of mental health medications for Medicaid members and identify prescribing patterns inconsistent with evidence-based guidelines. When needed, physicians will be provided with educational materials and client survey information as well as peer-to-peer consultation."
Group looks at more changes in mental health system (Georgia) Macon Telegraph story - "Georgia's mental health system is a shifting bureaucratic territory where frequent policy changes keep staff members and clients confused, where tangled inter-agency lines make it hard to get services and where those services are reaching only a fraction of the people in need. Those were just a few of the comments that emerged Friday when a task force appointed by Gov. Sonny Perdue met and invited the public to speak up. The Governor's Task Force on Community Care for Behavioral Health and Developmental Diseases is supposed to issue recommendations by July 12 for what could be another major overhaul of the state's mental health system."
Mental Illness Exacts Heavy Toll, Beginning in Youth National Institute of Health press release - "Researchers supported by the National Institute of Mental Health (NIMH) have found that half of all lifetime cases of mental illness begin by age 14, and that despite effective treatments, there are long delays sometimes decades between first onset of symptoms and when people seek and receive treatment. The study also reveals that an untreated mental disorder can lead to a more severe, more difficult to treat illness, and to the development of co-occurring mental illnesses. The landmark study is described in four papers that document the prevalence and severity of specific mental disorders. The papers provide significant new data on the impairment such as days lost from work caused by specific disorders, including mood, anxiety, and substance abuse disorders. These measures will allow researchers to determine the degree of disability and the economic burden caused by mental illness, as well as trends over time."
